Calidi Biotherapeutics, Inc. Other Noncash Income (Expense)
Calidi Biotherapeutics, Inc. (CLDI) reported Other Noncash Income (Expense) of -$14.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2024-05-14
- Calidi Biotherapeutics, Inc. other noncash income (expense) for the quarter ending 2023-03-31 was -$14.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 9 month |
|---|---|---|
| 2023-03-31 | -$14.00K 10-Q · filed 2024-05-14 | |
| 2022-09-30 | -$30.00K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |